Quantitative method, device and equipment based on multi-delay arterial spin labeling and storage medium

By performing blood inhibition on the target object in the multi-delay arterial spin labeling technology, the problem of blood signal interference when the delay time after labeling is short, and a more accurate analysis of cerebral hemodynamic parameters is achieved.

CN119024239APending Publication Date: 2024-11-26UNITED IMAGING RES INST OF INTELLIGENT IMAGING
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411060066.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In multi-delayed arterial spin labeling technology, blood signal interference and errors remaining in the arterial blood vessels when the delay time after labeling is short, resulting in underestimation or overestimation of cerebral hemodynamic parameters, affecting the accuracy of quantitative analysis.

Method used

By acquiring multiple post-label delay times, blood inhibition is performed on the target object, including dispersed and phase processing of the blood magnetization vector and static tissue magnetization vector, to inhibit blood signals in the arterial vessels and ensure the accuracy of the perfusion image.

Benefits of technology

It effectively avoids interference and errors of intravascular blood signals on quantitative analysis, improves the analysis accuracy of cerebral hemodynamic parameters, and avoids underestimation or overestimation of parameters.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119024239A_ABST
    Figure CN119024239A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of magnetic resonance perfusion imaging, and provides a quantitative method, device and equipment based on multi-delay artery spin labeling and a storage medium, which can perform more accurate quantitative analysis and avoid underestimation or overestimation of cerebral hemodynamic parameters. The method comprises the following steps: acquiring a plurality of marked delay times; marking a substance serving as an endogenous marker in the target object; starting from the marking moment and before the delay time after marking is reached, performing blood suppression on the target object; collecting an image from the marking moment when the delay time after marking is reached, and obtaining a perfusion image of the delay time after marking; and performing quantitative analysis based on the perfusion images corresponding to the plurality of marked delay times.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of magnetic resonance perfusion imaging, and in particular to a quantitative method, device, computer equipment, storage medium and computer program product based on multi-delay arterial spin labeling. Background Art

[0002] In the multi-delayed arterial spin labeling technique, cerebral hemodynamic parameters can be quantitatively analyzed by acquiring perfusion images corresponding to multiple delayed times after labeling.

[0003] However, the blood signal remaining in the arterial vessels during imaging, especially when the delay time after labeling is short, will cause interference and errors in quantitative analysis, leading to underestimation or overestimation of cerebral hemodynamic parameters. Summary of the invention

[0004] Based on this, it is necessary to provide a quantitative method, device, computer equipment, storage medium and computer program product based on multi-delay arterial spin labeling to address the above technical problems.

[0005] The present application provides a quantitative method based on multi-delay arterial spin labeling, the method comprising:

[0006] Get the delay time after multiple markers;

[0007] Labeling substances in the target object as endogenous markers;

[0008] Performing blood suppression on the target subject before reaching a delay time after the mark starting from the mark time;

[0009] Collecting images when the delay time after marking is reached starting from the marking time to obtain a perfusion image of the delay time after marking;

[0010] Quantitative analysis was performed based on the perfusion images corresponding to the delayed times after multiple labeling.

[0011] In one embodiment, performing blood suppression on the target subject comprises:

[0012] The blood magnetization vector of the target layer of the target object is dephased, and the static tissue magnetization vector of the target layer is first dephased and then converged to the main magnetic field direction.

[0013] In one embodiment, dephasing the blood magnetization vector at the target level of the target object, and first dephasing the static tissue magnetization vector at the target level and then focusing it back to the main magnetic field direction, include:

[0014] Dephasing the blood magnetization vector and the static tissue magnetization vector at the target level of the target object;

[0015] Refocusing the transverse magnetization vector of the static tissue magnetization vector at the target level;

[0016] The longitudinal magnetization vector of the static tissue magnetization vector of the target layer is turned toward the main magnetic field direction.

[0017] In one embodiment, performing blood suppression on the target subject comprises:

[0018] The phase coherence of the static tissue magnetization vector of the target layer of the target object is triggered, and the phase accumulation non-uniformity of the blood magnetization vector of the target layer is triggered.

[0019] In one embodiment, triggering the phase coherence of the static tissue magnetization vector of the target layer of the target object and triggering the phase accumulation non-uniformity of the blood magnetization vector of the target layer include:

[0020] Applying a plurality of continuous pre-pulses to the target object so as to make the phase of the static tissue magnetization vector of the target layer of the target object coherent and trigger the phase accumulation of the blood magnetization vector of the target layer to be non-uniform; wherein each pre-pulse includes a radio frequency pulse and a gradient field; the flip angle of the radio frequency pulse included in each of the pre-pulses is the same, and the size of the gradient field included in each of the pre-pulses is the same.

[0021] In one embodiment, performing blood suppression on the target subject comprises:

[0022] The blood magnetization vector located at the target layer of the target object and having a flow velocity value greater than a set value is dephased.

[0023] In one embodiment, quantitative analysis is performed based on the perfusion images corresponding to the multiple post-labeling delay times, including:

[0024] Cerebral hemodynamic parameters were quantitatively analyzed based on the perfusion images corresponding to multiple delayed times after labeling.

[0025] In one embodiment, the cerebral hemodynamic parameter comprises at least one of cerebral blood flow, arterial arrival time and arterial cerebral blood volume.

[0026] The present application provides a quantitative device based on multi-delay arterial spin labeling, the device comprising:

[0027] A time acquisition module is used to obtain delay times after multiple markings;

[0028] A labeling module, used for labeling a substance in a target object as an endogenous marker;

[0029] A blood suppression module, used to suppress blood on the target object from the marking time until the delay time after the marking is reached;

[0030] An image acquisition module, used to acquire an image when the delay time after the marking is reached starting from the marking moment, so as to obtain a perfusion image of the delay time after the marking;

[0031] The quantitative analysis module is used to perform quantitative analysis based on the perfusion images corresponding to the multiple post-labeling delay times.

[0032] The present application provides a computer device, including a memory and a processor, wherein the memory stores a computer program, and the processor executes the above method.

[0033] The present application provides a computer-readable storage medium having a computer program stored thereon, wherein the computer program is executed by a processor to execute the above method.

[0034] The present application provides a computer program product, on which a computer program is stored, and the computer program is executed by a processor to perform the above method.

[0035] The quantitative method, device, computer equipment, storage medium and computer program product based on multi-delay arterial spin labeling obtain multiple post-labeling delay times; label the substance in the target object as an endogenous marker; suppress the blood of the target object before reaching the post-labeling delay time starting from the marking time; collect images when the post-labeling delay time is reached starting from the marking time to obtain a perfusion image of the post-labeling delay time, in which the blood signal in the arterial blood vessel is suppressed, so that the perfusion image can be used for more accurate quantitative analysis, avoiding interference and errors in the quantitative analysis caused by the blood signal in the arterial blood vessel, and avoiding underestimation or overestimation of cerebral hemodynamic parameters. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] In order to more clearly illustrate the technical solutions in the embodiments of the present application or the related technologies, the drawings required for use in the embodiments or the related technical descriptions are briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0037] Figure 1 A schematic diagram of a quantitative method based on multi-delay arterial spin labeling in one embodiment;

[0038] Figure 2 is a schematic diagram of a multi-delay ASL sequence in one embodiment;

[0039] Figure 3This is a comparison diagram of the effects based on blood inhibition and without blood inhibition in one embodiment;

[0040] Figure 4 is a structural block diagram of a quantitative device based on multi-delay arterial spin labeling in one embodiment;

[0041] Figure 5 FIG. 4 is a diagram showing the internal structure of a computer device in one embodiment. DETAILED DESCRIPTION

[0042] In order to make the purpose, technical solution and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.

[0043] Reference to "embodiments" in this application means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present application. The appearance of the phrase in various locations in the specification does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described in this application may be combined with other embodiments.

[0044] The quantitative method based on multi-delay arterial spin labeling provided in the present application can be executed by a computer device, including: Figure 1 The steps shown are:

[0045] Step S101, obtaining a plurality of post-marking delay times.

[0046] The full name of arterial spin labeling in English is: arterial spin labeling, abbreviated as ASL in English. The basic imaging principle of ASL technology is: collect data twice to generate a pair of labeled images and control images. There is basically no difference in the static tissue signals in the labeled image and the control image. The biggest difference lies in whether the incoming blood flow is reversed. In the scenario of brain perfusion based on ASL technology, the labeling process mainly applies the labeling module to the neck for labeling. The water molecules in the labeled blood flowing into the artery are reversed 180°. After a certain period of time, the blood flows into the target layer. Since there is a difference between the labeled (reversed) blood and the unlabeled blood signal, the labeled image and the control image are silhouetted. After the static tissue signal is cut off, only the difference between the labeled blood flow signal and the unlabeled blood flow signal is displayed.

[0047] In the above process, the time from applying the label to acquiring the image can be called the post-labeling delay (PLD in English, the full name is post-labeling delay). In some scenarios, multiple PLDs will be set, such as PLD_1, PLD_2, ..., PLD_n. In this case, the ASL technology is called multi-delay ASL technology.

[0048] Step S102: labeling the substance serving as an endogenous marker in the target object.

[0049] The substance used as an endogenous marker in the target object may be a water molecule. The water molecules in the target object may be labeled.

[0050] Step S103, performing blood suppression on the target object before reaching the delay time after the mark starting from the mark time.

[0051] In the case of multiple post-marking delay times, after each marking, a pulse and gradient for blood suppression are applied to the target object before reaching a certain post-marking delay time starting from the marking time, and image acquisition is performed when the post-marking delay time is reached starting from the marking time.

[0052] Take PLD_1, PLD_2 and PLD_3 as examples:

[0053] After the water molecules of the target object are marked, a pulse and a gradient for blood suppression are applied to the target object before reaching PLD_1 from the marked time, and image acquisition is performed when reaching PLD_1 from the marked time.

[0054] After the water molecules of the target object are marked again, a pulse and a gradient for blood suppression are applied to the target object before reaching PLD_2 from the marking time, and image acquisition is performed when reaching PLD_2 from the marking time.

[0055] After the water molecules of the target object are marked again, a pulse and gradient for blood suppression are applied to the target object before reaching PLD_3 from the marking time, and image acquisition is performed when reaching PLD_3 from the marking time.

[0056] Step S104, when the delay time after marking is reached starting from the marking time, an image is acquired to obtain a perfusion image of the delay time after marking.

[0057] Exemplarily, after the water molecules of the target object are marked, a pulse and gradient for blood suppression are applied to the target object before reaching PLD_1 starting from the marking time, and a magnetic field for image acquisition can be applied when reaching PLD_1 starting from the marking time to acquire images and obtain a perfusion image corresponding to PLD_1.

[0058] As another example, after the water molecules of the target object are marked again, a pulse and gradient for blood suppression are applied to the target object before reaching PLD_2 starting from the marking time, and a magnetic field for image acquisition can be applied when reaching PLD_2 starting from the marking time to acquire images and obtain a perfusion image corresponding to PLD_2.

[0059] As another example, after the water molecules of the target object are marked again, a pulse and gradient for blood suppression are applied to the target object before reaching PLD_3 starting from the marking time, and a magnetic field for image acquisition can be applied when reaching PLD_3 starting from the marking time to acquire the image and obtain the perfusion image corresponding to PLD_3.

[0060] Step S105 : performing quantitative analysis based on the perfusion images corresponding to the multiple post-labeling delay times.

[0061] After obtaining the perfusion image corresponding to PLD_1, the perfusion image corresponding to PLD_2, and the perfusion image corresponding to PLD_3, quantitative analysis may be performed based on these perfusion images to obtain parameter values ​​of cerebral hemodynamic parameters.

[0062] In the above embodiment, a plurality of post-marking delay times are obtained; a substance serving as an endogenous marker in the target object is marked; blood suppression is performed on the target object before the post-marking delay time is reached starting from the marking moment; an image is acquired starting from the marking moment when the post-marking delay time is reached to obtain a perfusion image of the post-marking delay time, in which the blood signal in the arterial blood vessel is suppressed, so that a more accurate quantitative analysis can be performed using the perfusion image, thereby avoiding interference and errors in the quantitative analysis caused by the blood signal in the arterial blood vessel, and avoiding underestimation or overestimation of cerebral hemodynamic parameters.

[0063] In one embodiment, blood suppression is performed on the target object, which may specifically include the following steps: dephasing the blood magnetization vector at the target level of the target object, and first dephasing and then focusing the static tissue magnetization vector at the target level back to the main magnetic field direction.

[0064] Specifically, a magnetic field for dephasing can be applied to the target layer of the target object, so that the blood magnetization vector and the static tissue magnetization vector at the target layer are dephased; after applying the magnetic field for dephasing, a magnetic field for refocusing can be applied to the target layer of the target object, so that the transverse magnetization vector of the static tissue magnetization vector at the target layer is refocused; after applying the magnetic field for refocusing, a magnetic field for steering can be applied to the target layer of the target object, so that the longitudinal magnetization vector of the static tissue magnetization vector at the target layer returns to the direction of the main magnetic field.

[0065] In this embodiment, the static tissue magnetization vector at the target level is first dispersed and then converged to the main magnetic field direction. This process will not produce changes in the static magnetization vector for the static tissue. The blood magnetization vector at the target level of the target object is dispersed and the blood magnetization vector does not converge. This process prevents the blood signal from undergoing a complete convergence process, thereby suppressing the blood signal in the blood vessel. The blood signal contained in the large blood vessels of the perfusion image obtained thereby is lower, thereby improving the accuracy of quantitative analysis.

[0066] In one embodiment, the blood magnetization vector of the target layer of the target object is dispersed, and the static tissue magnetization vector of the target layer is first dispersed and then converged to the main magnetic field direction. Specifically, the following steps may be included: the blood magnetization vector and the static tissue magnetization vector of the target layer of the target object are dispersed; the transverse magnetization vector of the static tissue magnetization vector of the target layer is converged; and the longitudinal magnetization vector of the static tissue magnetization vector of the target layer is turned to the main magnetic field direction.

[0067] Specifically, a 90° RF pulse and a spoiler gradient may be applied first to dephase the blood magnetization vector and the static tissue magnetization vector at the target level of the target object; then, a 180° RF pulse and a gradient identical to the spoiler gradient may be applied. Since the blood will flow, when a 180° RF pulse and a gradient identical to the spoiler gradient are applied, the dephased blood has already flowed out of the target level, while the dephased static tissue remains at the target level. Therefore, the dephased blood will not be refocused, while the dephased static tissue will be refocused. The blood signal will not undergo a complete refocusing process, while the static tissue will undergo a complete refocusing process. Then, a 90° RF pulse may be applied to turn the longitudinal magnetization vector of the static tissue magnetization vector to the direction of the main magnetic field. Therefore, this process will not produce a change in the static magnetization vector of the static tissue.

[0068] In the above embodiment, since the blood will flow, when the blood magnetization vector and the static tissue magnetization vector at the target level of the target object are dispersed and then converged and turned, the dispersed blood flows out of the target level and will not undergo the convergence and turning process, thereby suppressing the blood signal, while the static tissue remains at the target level and will undergo the convergence and turning process, and for the static tissue, no change in the static magnetization vector will occur.

[0069] In one embodiment, performing blood suppression on the target object may specifically include the following steps: triggering phase coherence of static tissue magnetization vectors at a target level of the target object, and triggering non-uniform phase accumulation of blood magnetization vectors at the target level.

[0070] Static tissue has different phase coherence from flowing tissue such as blood. For static tissue, the phase of the excitation pulse is a fixed increment, and the phase accumulated by the transverse magnetization in each pulse interval is the same, so the phase coherence is satisfied. For blood, however, the phase accumulation of the magnetization vector is coherent with factors such as time, blood flow velocity, and blood flow direction, and they are not unified with each other, so the blood signal will be suppressed.

[0071] When blood suppression is performed on the target object, a corresponding magnetic field may be applied to make the static tissue magnetization vector of the target layer of the target object phase coherent and the phase accumulation of the blood magnetization vector of the target layer non-uniform.

[0072] This embodiment utilizes the different phase coherences of static tissue and blood to make the static tissue magnetization vector at the target level phase coherent and the phase accumulation of the blood magnetization vector at the target level non-uniform, thereby suppressing blood signals.

[0073] In one embodiment, triggering the phase coherence of the static tissue magnetization vector of the target layer of the target object and triggering the phase accumulation non-uniformity of the blood magnetization vector of the target layer can specifically include the following steps: applying a plurality of consecutive pre-pulses to the target object to make the phase coherence of the static tissue magnetization vector of the target layer of the target object and triggering the phase accumulation non-uniformity of the blood magnetization vector of the target layer; wherein each pre-pulse includes a radio frequency pulse and a gradient field; the flip angle of the radio frequency pulse included in each pre-pulse is the same, and the magnitude of the gradient field included in each pre-pulse is the same.

[0074] Before image acquisition, a series of pre-pulses can be applied, each pre-pulse includes a radio frequency pulse and a gradient field, the flip angles of the radio frequency pulses included in each pre-pulse are the same, and the flip angles of each radio frequency pulse are small, and the areas of the gradient fields included in each pre-pulse are the same.

[0075] In the multi-delay ASL technology, the number of pre-pulses, the flip angle of the RF pulse, the intensity of the gradient field, the duration of the gradient field, the interval time of the pre-pulse and other parameters can be specifically optimized according to the blood flow velocity of the intracranial arteries, especially the slow blood flow in disease conditions, so that the optimal combination can effectively reduce the signal intensity of the flow spins remaining in the blood vessels and achieve a better and more stable blood suppression effect.

[0076] This embodiment applies multiple consecutive pre-pulses to the target object, and the flip angle of the radio frequency pulse included in each pre-pulse is the same and the size of the gradient field included in each pre-pulse is the same. It is suitable for blood suppression in thicker layers and has less impact on tissue contrast.

[0077] In one embodiment, performing blood suppression on the target object includes: dephasing the blood magnetization vector located at the target layer of the target object and having a flow rate value above a set value.

[0078] Specifically, a specific gradient can be applied to the target layer of the target object to cause the blood magnetization vector at the target layer with a flow rate value above a set value to be dephased; the gradient can include a pair of bipolar gradients, the pair of bipolar gradients include a positive gradient and a negative gradient, there is no gap between the positive gradient and the negative gradient, and the magnitudes of the positive gradient and the negative gradient are set by a velocity encoding value (which can be denoted as Venc) to cause the blood magnetization vector at the target layer with a flow rate value above Venc to be dephased.

[0079] In this embodiment, by de-phasing the blood magnetization vectors with flow velocity values ​​above the set value at the target level, magnetization vectors such as static tissue magnetization vectors with flow velocity values ​​below the set value will not be de-phased, and there is no need to refocus the static tissue magnetization vectors.

[0080] In one embodiment, the quantitative analysis based on the perfusion images corresponding to the multiple post-marking delay times may specifically include the following steps: quantitatively analyzing the cerebral hemodynamic parameters based on the perfusion images corresponding to the multiple post-marking delay times.

[0081] Exemplarily, after obtaining the perfusion image corresponding to PLD_1, the perfusion image corresponding to PLD_2, and the perfusion image corresponding to PLD_3, quantitative fitting processing can be performed based on these perfusion images and the hemodynamic model to obtain parameter values ​​of cerebral hemodynamic parameters.

[0082] In this embodiment, blood suppression is performed before image acquisition, so that the blood signal in the arterial blood vessels in the obtained perfusion images is suppressed. The quantitative analysis based on these perfusion images is more accurate, and more accurate cerebral hemodynamic parameters can be obtained, thereby avoiding underestimation or overestimation of cerebral hemodynamic parameters.

[0083] In one embodiment, the cerebral hemodynamic parameter includes at least one of cerebral blood flow, arterial arrival time, and arterial cerebral blood volume.

[0084] The English abbreviation of cerebral blood flow is CBF, which stands for Cerebral Blood Flow. The English abbreviation of arterial arrival time is ATT, which stands for Arterial Transit Time. The English abbreviation of arterial cerebral blood volume is aCBV, which stands for Arterial Cerebral Blood Volume.

[0085] In this embodiment, accurate quantitative analysis can be performed with the help of perfusion images in which the blood signal in the arterial blood vessels is suppressed, thereby avoiding interference and errors in the quantitative analysis caused by the blood signal in the arterial blood vessels, avoiding overestimation of CBF and underestimation of ATT, and obtaining a more accurate aCBV.

[0086] In order to better understand the above method, an application example of the quantitative method based on multi-delay arterial spin labeling of the present application is described in detail below.

[0087] Reference Figure 2 , Figure 2 A multi-delay ASL sequence is shown, which includes four subsequences, each of which includes: a pre-saturation module, a marking module, a background suppression module applied in sequence with a delay time after interval marking, a blood suppression module and an image acquisition module; wherein the delay time after marking of each subsequence is different, which are respectively denoted as PLD_1, PLD_2, PLD_3 and PLD_4. Figure 3 The comparison effect diagram of applying the blood inhibition module and not applying the blood inhibition module is shown. Water molecules in the arterial blood vessels are marked at the microvascular components of the first group and the second group; the blood inhibition module is applied to the first group before the delay after reaching the mark from the marking moment to perform blood inhibition on the target object; the blood inhibition module is not applied to the second group; the image acquisition module is applied to the marking bands of the first group and the second group at the delay after reaching the mark from the marking moment to obtain the perfusion image at the marking band of the first group and the perfusion image at the marking band of the second group; in the perfusion image at the marking band of the first group, the blood signal in the arterial blood vessel is suppressed, and in the perfusion image at the marking band of the second group, the blood signal in the arterial blood vessel is not suppressed.

[0088] The first subsequence is executed first, and the magnetic field corresponding to the pre-saturation module can be applied. Then the marking module is applied to mark the substance in the target object as an endogenous marker. Starting from the marking moment, the background suppression module is applied first and then the blood suppression module is applied before reaching PLD_1 to suppress the blood of the target object. Starting from the marking moment, the image acquisition module is applied when reaching PLD_1 to obtain the perfusion image corresponding to PLD_1.

[0089] The second subsequence is then executed to apply a magnetic field corresponding to the pre-saturation module, and then the marking module is applied to mark the substance in the target object as an endogenous marker. Starting from the marking moment, the background suppression module is applied first and then the blood suppression module is applied before reaching PLD_2 to suppress blood on the target object. Starting from the marking moment, the image acquisition module is applied when reaching PLD_2 to obtain a perfusion image corresponding to PLD_2.

[0090] Next, the third subsequence is executed to apply a magnetic field corresponding to the pre-saturation module, and then the marking module is applied to mark the substance in the target object as an endogenous marker. Starting from the marking moment, the background suppression module is applied first and then the blood suppression module is applied before reaching PLD_3 to perform blood suppression on the target object. Starting from the marking moment, the image acquisition module is applied when reaching PLD_3 to obtain the perfusion image corresponding to PLD_3.

[0091] Then, the fourth subsequence is executed to apply a magnetic field corresponding to the pre-saturation module, and then the marking module is applied to mark the substance in the target object as an endogenous marker. Starting from the marking moment, the background suppression module is applied first and then the blood suppression module is applied before reaching PLD_4 to suppress blood on the target object. Starting from the marking moment, the image acquisition module is applied when reaching PLD_4 to obtain the perfusion image corresponding to PLD_4.

[0092] The blood suppression module may include a first type of blood suppression module and a second type of blood suppression module. The first type of blood suppression module is used to disperse the phase of the blood magnetization vector at the target level of the target object, and to disperse the phase of the static tissue magnetization vector at the target level and then converge it to the main magnetic field direction; the second type of blood suppression module is used to keep the phase coherence of the static tissue magnetization vector at the target level of the target object and the phase accumulation of the blood magnetization vector at the target level non-uniform; the third type of blood suppression module is used to disperse the phase of the blood magnetization vector at the target level of the target object and whose flow rate value is above the set value.

[0093] After obtaining the perfusion images corresponding to PLD_1, PLD_2, PLD_3, and PLD_4, quantitative analysis can be performed based on these perfusion images to obtain CBF, ATT, and aCBV.

[0094] In this embodiment, a blood suppression module is first applied before the image acquisition module is applied to suppress blood on the target object, so that the intravascular blood signal in the perfusion image obtained is suppressed, thereby performing a more accurate quantitative analysis, avoiding interference and errors in the quantitative analysis caused by the intravascular blood signal of the arterial blood vessel, avoiding overestimation of CBF and underestimation of ATT, and also obtaining a more accurate aCBV.

[0095] It should be understood that, although the various steps in the flowcharts involved in the above-mentioned embodiments are displayed in sequence according to the indication of the arrows, these steps are not necessarily executed in sequence according to the order indicated by the arrows. Unless there is a clear explanation in this article, the execution of these steps does not have a strict order restriction, and these steps can be executed in other orders. Moreover, at least a part of the steps in the flowcharts involved in the above-mentioned embodiments can include multiple steps or multiple stages, and these steps or stages are not necessarily executed at the same time, but can be executed at different times, and the execution order of these steps or stages is not necessarily to be carried out in sequence, but can be executed in turn or alternately with other steps or at least a part of the steps or stages in other steps.

[0096] Based on the same inventive concept, the embodiment of the present application also provides a quantitative device based on multi-delay arterial spin labeling for implementing the quantitative method based on multi-delay arterial spin labeling involved above. The implementation scheme for solving the problem provided by the device is similar to the implementation scheme recorded in the above method, so the specific limitations in one or more embodiments of the quantitative device based on multi-delay arterial spin labeling provided below can refer to the limitations of the quantitative method based on multi-delay arterial spin labeling above, and will not be repeated here.

[0097] In one embodiment, Figure 4 As shown, a quantitative device based on multi-delay arterial spin labeling is provided, comprising:

[0098] A time acquisition module 401 is used to acquire a plurality of post-marking delay times;

[0099] The labeling module 402 is used to label the substance in the target object as an endogenous marker;

[0100] A blood suppression module 403, configured to suppress blood on the target object from the time of marking until the delay time after the marking is reached;

[0101] An image acquisition module 404 is used to acquire an image when the delay time after the marking is reached from the marking moment, so as to obtain a perfusion image of the delay time after the marking;

[0102] The quantitative analysis module 405 is used to perform quantitative analysis based on the perfusion images corresponding to the multiple post-labeling delay times.

[0103] In one embodiment, the blood suppression module 403 is further used to: disperse the phase of the blood magnetization vector of the target layer of the target object, and disperse the phase of the static tissue magnetization vector of the target layer and then converge it to the main magnetic field direction.

[0104] In one embodiment, the blood suppression module 403 is further used to: disperse the blood magnetization vector and the static tissue magnetization vector at the target level of the target object; converge the transverse magnetization vector of the static tissue magnetization vector at the target level; and turn the longitudinal magnetization vector of the static tissue magnetization vector at the target level to the direction of the main magnetic field.

[0105] In one embodiment, the blood suppression module 403 is further configured to: trigger phase coherence of static tissue magnetization vectors at a target level of the target object, and trigger phase accumulation non-uniformity of blood magnetization vectors at the target level.

[0106] In one embodiment, the blood suppression module 403 is further used to: apply a plurality of consecutive pre-pulses to the target object to make the static tissue magnetization vector of the target layer of the target object phase coherent, and trigger the phase accumulation of the blood magnetization vector of the target layer to be non-uniform; wherein each pre-pulse includes a radio frequency pulse and a gradient field; the flip angle of the radio frequency pulse included in each of the pre-pulses is the same, and the size of the gradient field included in each of the pre-pulses is the same.

[0107] In one embodiment, the blood suppression module 403 is further used to disperse the blood magnetization vector located at the target layer of the target object and having a flow rate value above a set value.

[0108] In one embodiment, the quantitative analysis module 405 is further used to: perform quantitative analysis on cerebral hemodynamic parameters based on the perfusion images corresponding to the multiple post-marking delay times.

[0109] In one embodiment, the cerebral hemodynamic parameter comprises at least one of cerebral blood flow, arterial arrival time and arterial cerebral blood volume.

[0110] Each module in the above-mentioned quantitative device based on multi-delayed arterial spin labeling can be implemented in whole or in part by software, hardware and a combination thereof. Each of the above-mentioned modules can be embedded in or independent of a processor in a computer device in the form of hardware, or can be stored in a memory in a computer device in the form of software, so that the processor can call and execute the operations corresponding to each of the above modules.

[0111] In an exemplary embodiment, a computer device is provided, the internal structure of which can be shown as follows: Figure 5As shown. The computer device includes a processor, a memory, an input / output interface (Input / Output, referred to as I / O) and a communication interface. The processor, the memory and the input / output interface are connected through a system bus, and the communication interface is connected to the system bus through the input / output interface. The processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system, a computer program and a database. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The database of the computer device is used to store the data involved in the above-mentioned embodiments. The input / output interface of the computer device is used to exchange information between the processor and an external device. The communication interface of the computer device is used to communicate with an external terminal through a network connection. When the computer program is executed by the processor, a quantitative method based on multi-delay arterial spin labeling is implemented.

[0112] Those skilled in the art will understand that Figure 5 The structure shown in the figure is only a block diagram of a part of the structure related to the solution of the present application, and does not constitute a limitation on the computer device to which the solution of the present application is applied. The specific computer device may include more or fewer components than those shown in the figure, or combine certain components, or have a different arrangement of components.

[0113] In one embodiment, a computer device is provided, including a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps in the above-mentioned various method embodiments when executing the computer program.

[0114] In one embodiment, a computer-readable storage medium is provided, on which a computer program is stored. When the computer program is executed by a processor, the steps in the above-mentioned method embodiments are implemented.

[0115] In one embodiment, a computer program product is provided, on which a computer program is stored, and the computer program is used by a processor to execute the steps in the above-mentioned various method embodiments.

[0116] It should be noted that the user information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data used for analysis, stored data, displayed data, etc.) involved in this application are all information and data authorized by the user or fully authorized by all parties, and the collection, use and processing of relevant data must comply with relevant regulations.

[0117] Those skilled in the art can understand that all or part of the processes in the above-mentioned embodiment methods can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to the memory, database or other medium used in the embodiments provided in this application can include at least one of non-volatile and volatile memory. Non-volatile memory can include read-only memory (ROM), magnetic tape, floppy disk, flash memory, optical memory, high-density embedded non-volatile memory, resistive random access memory (ReRAM), magnetoresistive random access memory (MRAM), ferroelectric random access memory (FRAM), phase change memory (PCM), graphene memory, etc. Volatile memory can include random access memory (RAM) or external cache memory, etc. As an illustration and not limitation, RAM can be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM). The database involved in each embodiment provided in this application may include at least one of a relational database and a non-relational database. Non-relational databases may include distributed databases based on blockchains, etc., but are not limited to this. The processor involved in each embodiment provided in this application may be a general-purpose processor, a central processing unit, a graphics processor, a digital signal processor, a programmable logic device, a data processing logic device based on quantum computing, etc., but are not limited to this.

[0118] The technical features of the above embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0119] The above-described embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be construed as limiting the scope of the present application. It should be noted that, for a person of ordinary skill in the art, several modifications and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the present application shall be subject to the attached claims.

Claims

1. A quantitative method based on multi-delay arterial spin labeling, characterized in that: The method comprises: Get the delay time after multiple markers; Labeling substances in the target object as endogenous markers; Performing blood suppression on the target subject before reaching a delay time after the mark starting from the mark time; Collecting images when the delay time after marking is reached starting from the marking time to obtain a perfusion image of the delay time after marking; Quantitative analysis was performed based on the perfusion images corresponding to the delayed times after multiple labeling.

2. The method according to claim 1, characterized in that Performing blood suppression on the target subject comprises: The blood magnetization vector of the target layer of the target object is dephased, and the static tissue magnetization vector of the target layer is first dephased and then converged to the main magnetic field direction.

3. The method according to claim 2, characterized in that Dephasing the blood magnetization vector at the target level of the target object, and first dephasing and then focusing the static tissue magnetization vector at the target level back to the main magnetic field direction, including: Dephasing the blood magnetization vector and the static tissue magnetization vector at the target level of the target object; Refocusing the transverse magnetization vector of the static tissue magnetization vector at the target level; The longitudinal magnetization vector of the static tissue magnetization vector of the target layer is turned toward the main magnetic field direction.

4. The method according to claim 1, characterized in that Performing blood suppression on the target subject comprises: The phase coherence of the static tissue magnetization vector of the target layer of the target object is triggered, and the phase accumulation non-uniformity of the blood magnetization vector of the target layer is triggered.

5. The method according to claim 4, characterized in that Triggering the phase coherence of the static tissue magnetization vector of the target layer of the target object and triggering the phase accumulation non-uniformity of the blood magnetization vector of the target layer include: Applying a plurality of continuous pre-pulses to the target object so as to make the phase of the static tissue magnetization vector of the target layer of the target object coherent and trigger the phase accumulation of the blood magnetization vector of the target layer to be non-uniform; wherein each pre-pulse includes a radio frequency pulse and a gradient field; the flip angle of the radio frequency pulse included in each of the pre-pulses is the same, and the size of the gradient field included in each of the pre-pulses is the same.

6. The method according to claim 1, characterized in that Performing blood suppression on the target subject comprises: The blood magnetization vector located at the target layer of the target object and having a flow velocity value greater than a set value is dephased.

7. The method according to claim 1, characterized in that Quantitative analysis based on the perfusion images corresponding to multiple post-labeling delay times, including: Cerebral hemodynamic parameters were quantitatively analyzed based on the perfusion images corresponding to multiple delayed times after labeling.

8. A quantitative device based on multi-delay arterial spin labeling, characterized in that: The device comprises: A time acquisition module is used to obtain delay times after multiple markings; A labeling module, used for labeling a substance in a target object as an endogenous marker; A blood suppression module, used to suppress blood on the target object from the marking time until the delay time after the marking is reached; An image acquisition module, used to acquire an image when the delay time after the marking is reached starting from the marking moment, so as to obtain a perfusion image of the delay time after the marking; The quantitative analysis module is used to perform quantitative analysis based on the perfusion images corresponding to the multiple post-labeling delay times.

9. A computer device comprising a memory and a processor, wherein the memory stores a computer program, wherein: When the processor executes the computer program, the method according to any one of claims 1 to 7 is implemented.

10. A computer-readable storage medium having a computer program stored thereon, characterized in that: When the computer program is executed by a processor, the method according to any one of claims 1 to 7 is implemented.